2021
DOI: 10.1002/mds.28501
|View full text |Cite
|
Sign up to set email alerts
|

Longevity of Deep Brain Stimulation Batteries; a Global Survey of Neurosurgeons and Neurologists

Abstract: Deep brain simulation (DBS) is a routine surgical treatment for Parkinson's disease (PD) and other movement disorders. Although there are currently several DBS manufacturers (Medtronic Inc, Minneapolis, Mn, USA), the hardware of the historically oldest DBS company is still the most prevalent. 1 Its original implantable pulse generators (IPGs), the dual channel Kinetra and the single channel Soletra, were used in many trials, including in the randomized blinded trials of DBS for PD and dystonia that established… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 6 publications
1
0
0
Order By: Relevance
“…During the study, this IPG model was replaced by the company with a new model, the Activa PC. In all patients in whom this model was used, the battery was depleted within 10 years, supporting previous studies reporting a 35% reduction of the battery longevity in the new model 21 . However, the new programming options available in the new model, such as interleaving stimulation did actually solve one case of suboptimal treatment effect and one case of stimulation induced side effects in the present cohort.…”
Section: Discussionsupporting
confidence: 86%
“…During the study, this IPG model was replaced by the company with a new model, the Activa PC. In all patients in whom this model was used, the battery was depleted within 10 years, supporting previous studies reporting a 35% reduction of the battery longevity in the new model 21 . However, the new programming options available in the new model, such as interleaving stimulation did actually solve one case of suboptimal treatment effect and one case of stimulation induced side effects in the present cohort.…”
Section: Discussionsupporting
confidence: 86%